000 | 05361nam a22003735i 4500 | ||
---|---|---|---|
001 | 291673 | ||
003 | MX-SnUAN | ||
005 | 20160429154911.0 | ||
007 | cr nn 008mamaa | ||
008 | 150903s2006 xxk| o |||| 0|eng d | ||
020 |
_a9781846280092 _99781846280092 |
||
024 | 7 |
_a10.1007/b136178 _2doi |
|
035 | _avtls000343579 | ||
039 | 9 |
_a201509031112 _bVLOAD _c201405070503 _dVLOAD _y201402061159 _zstaff |
|
040 |
_aMX-SnUAN _bspa _cMX-SnUAN _erda |
||
050 | 4 | _aRC1-1245 | |
100 | 1 |
_aKhamashta, M. A. _eeditor. _9323077 |
|
245 | 1 | 0 |
_aHughes Syndrome : _bAntiphospholipid Syndrome / _cedited by M. A. Khamashta. |
250 | _aSecond Edition. | ||
264 | 1 |
_aLondon : _bSpringer London, _c2006. |
|
300 |
_axxii, 602 páginas 77 ilustraciones, 47 en color. _brecurso en línea. |
||
336 |
_atexto _btxt _2rdacontent |
||
337 |
_acomputadora _bc _2rdamedia |
||
338 |
_arecurso en línea _bcr _2rdacarrier |
||
347 |
_aarchivo de texto _bPDF _2rda |
||
500 | _aSpringer eBooks | ||
505 | 0 | _aClinical Aspects -- Hughes Syndrome: History -- Antiphospholipid (Hughes) Syndrome: An Overview -- Epidemiology of Antiphospholipid Syndrome -- Hemocytopenias in Antiphospholipid Syndrome -- Cardiac Manifestations in Antiphospholipid Syndrome -- Cerebral Ischemia in Antiphospholipid Syndrome -- Cerebral Disease Other than Stroke and Transient Ischemic Attack in Antiphospholipid Syndrome -- Skin Manifestations of Antiphospholipid Syndrome -- Kidney Disease in Antiphospholipid Syndrome -- Systemic Hypertension in Antiphospholipid Syndrome -- Pulmonary Hypertension and Antiphospholipid Antibodies -- Osteoarticular Manifestations of Antiphospholipid Syndrome -- The Ear and Antiphospholipid Syndrome -- The Eye in Primary Antiphospholipid Syndrome -- Primary Antiphospholipid Syndrome -- Catastrophic Antiphospholipid Syndrome -- Obstetric Antiphospholipid Syndrome -- Infertility and Antiphospholipid Antibodies -- Transplantation of Solid Organs, Tissues, and Prosthetic Devices in Patients with Antiphospholipid Antibodies -- Antiphospholipid Syndrome in Children -- Ethnic and Geographic Variation in Antiphospholipid Syndrome -- Antiphospholipid Syndrome: Differential Diagnosis -- Laboratory Investigation -- Anticardiolipin Testing -- Lupus Anticoagulants: Mechanistic and Diagnostic Considerations -- ?2-glycoprotein I and Anti-?2-glycoprotein I Antibodies -- Antiprothrombin Antibodies -- Antiphospholipid Syndrome in the Absence of Standard Antiphospholipid Antibodies: Associations with Other Autoantibodies -- Basic Aspects -- Vascular Pathology of Antiphospholipid Antibody Syndrome -- Placental Pathology in Antiphospholipid Syndrome -- Antiphospholipid Syndrome — Experimental Models: Insight into Etiology, Pathogenesis, and Treatments -- Antiphospholipid Antibody-Induced Pregnancy Loss and Thrombosis -- Mechanism of Thrombosis in Antiphospholipid Syndrome: Binding to Platelets -- Interaction of Antiphospholipid Antibodies with Endothelial Cells -- The Influence of Antiphospholipid Antibodies on the Protein C Pathway -- Contribution of Tissue Factor to the Pathogenesis of Thrombosis in Patients with Antiphospholipid Syndrome -- Annexins in Antiphospholipid Syndrome -- Plasminogen Activation, Fibrinolysis, and Cell Proteolytic Activity in Antiphospholipid Syndrome -- Lessons from Sequence Analysis of Monoclonal Antiphospholipid Antibodies -- Apoptosis and Antiphospholipid Antibodies -- Accelerated Atherogenesis and Antiphospholipid Antibodies -- Genetics of Antiphospholipid Syndrome -- Infection and Drug-Induced Antiphospholipid Antibodies -- Therapy -- Management of Thrombosis in Antiphospholipid Syndrome -- Management of Antiphospholipid Syndrome in Pregnancy -- Management of Thrombocytopenia in Hughes Syndrome -- The Future of Hughes Syndrome. | |
520 | _aThe second edition of Hughes Syndrome: Antiphospholipid Syndrome addresses the complete range of conditions produced by this common disorder which is also known as APS or "sticky blood" syndrome. APS is one of the main causes of strokes (40%), leg deep vein thrombosis, and recurrent miscarriages in women. It is an important risk factor for thrombosis in women taking the oral contraceptive pill. The effects of this syndrome were found initially in thrombosis, obstetrics (APS is the most common treatable cause of recurrent pregnancy loss) and neurology. Its impact is now felt in a diverse range of conditions. These include surgery (graft rejection), orthopedics (avascular necrosis, DVT), psychiatry (memory loss), cardiology (pulmonary hypertension, valvular disease, angina), ENT (vertigo), pediatrics (young strokes, epilepsy) to name but a few. This new and updated text reflects the growth in published literature on APS and the widening ramifications of the disease. APS is a multi-specialty disease and is of increasing interest to obstetricians, rheumatologists, hematologists, dermatologists, neurologists and immunologists. | ||
590 | _aPara consulta fuera de la UANL se requiere clave de acceso remoto. | ||
710 | 2 |
_aSpringerLink (Servicio en línea) _9299170 |
|
776 | 0 | 8 |
_iEdición impresa: _z9781852338732 |
856 | 4 | 0 |
_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/b136178 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
942 | _c14 | ||
999 |
_c291673 _d291673 |